Although the World Symposium on Pulmonary Hypertension (WSPH) has led pulmonary hypertension (PH) to be considered in five classifications, or groups, pediatric PH is more nuanced and there is increasing recognition of unique genotypic and phenotypic subsets of the disease. This necessitates individualized and precision approaches to treatments for children with PH that will likely be different than adults with PH. This is the conclusion of Rachel K. Hopper, M.D., Division of Cardiology Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children’s Hospital Stanford, Palo Alto, Calif., and Mary P. Mullen, M.D., Ph.D., Department of Cardiology, Boston Children’s Hospital, Boston, discussed in the latest issue of Advances in Pulmonary Hypertension.

Advances now is exclusively available online at Register at to read Advances for free as a service to the PH community, and to receive an email alert when a new issue is posted online. Benefits of registering include:

  • Sharing articles with your peers around the globe.
  • Creating a favorites list for frequently accessed articles.
  • Viewing abstracts and exporting citations.

Do not miss an issue. Register today.